Navigation Links
Anadys Retains Lazard as Strategic Advisor
Date:5/26/2010

SAN DIEGO, May 26 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) today announced that it has retained Lazard Freres & Co. LLC as its strategic advisor as it pursues various avenues aimed at value recognition for its stockholders from its non-nucleoside polymerase inhibitor, ANA598, in development for the treatment of hepatitis C.  Anadys recently released positive safety and antiviral response data at the conclusion of 12 weeks of dosing ANA598 in combination with pegylated interferon and ribavirin (current standard of care, or SOC) in an ongoing Phase II study.

"The impressive safety and antiviral response data we recently released establish a very attractive profile for ANA598," said Steve Worland, Ph.D., President and CEO of Anadys.  "We look forward to working with Lazard as we pursue options to maximize recognition of the value inherent in the ANA598 program."

Recently Released ANA598 Data

Anadys recently reported that patients treated with ANA598 at 400 mg bid demonstrated excellent safety through 12 weeks and that 75% of patients at this dose level achieved undetectable levels of virus (<15 /IU/mL) at week 12, known as complete Early Virological Response or cEVR.  These data confirmed the positive profile previously reported for ANA598 at 200 mg bid through 12 weeks.  Based on comparable antiviral potency and excellent safety at both doses, Anadys has identified 200 mg bid as the optimal dose to advance in combination with current SOC in future clinical trials.  Anadys believes that lower doses and once daily dosing also merit exploration, especially in combin
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference
2. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
3. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
4. Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
5. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
6. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
10. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
11. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... the addition of the "Immunoprotein Diagnostic Testing ... at the highest CAGR of 6% and is ... report to their offering. ... for immunoprotein diagnostic testing has been segmented according ...
(Date:7/10/2014)... 2014  Major advances in radiation therapy and ... highlighted in a three-day Oncology Summit taking place ... 2014.  Renowned national and international cancer experts from seven ... exchange knowledge on modern technologies making treatment for ... The Summit will address a wide ...
(Date:7/10/2014)... -- Integrated Silicon Solution, Inc. (Nasdaq: ISSI ... solutions, today announced that it will host its earnings ... a.m. Pacific Time (10:00 a.m. Eastern Time) to discuss ... quarter ended June 30, 2014. To access ... a.m. Pacific time on July 24, 2014.  The participant ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... 16 Patients and clinicians should consider risk factors ... smoking and risk of gastrointestinal bleeding -- before deciding ... strokes, according to new recommendations from the U.S. Preventive ... to people who have already had a heart attack ...
... Healthpoint today announced that it has initiated a Phase ... venous leg ulcers. HP802-247 is a topical spray containing ... determine the effectiveness of two cell concentrations and two ... compared to placebo plus standard care, in healing venous ...
Cached Medicine Technology:Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms 2Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms 3Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers 2Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers 3
(Date:7/14/2014)... Calgary, Alberta, Canada (PRWEB) July 14, 2014 ... the “Trusted Authority in Turning Information into Money,” ... Spotfire® Partner Network, a global program that helps ... or embed the TIBCO Spotfire® analytics platform. TIBCO ... and business intelligence software, including TIBCO Spotfire analytics, ...
(Date:7/13/2014)... 14, 2014 The special two-day sale starts ... Sublime Beauty®. Use coupon code 20SCRUB at the webstore checkout. ... who tries the Fresh Citrus Scrub falls in love with ... is a perfect little cleanser for face, but can also ... beads that help to exfoliate with pleasure, clean pores and ...
(Date:7/13/2014)... Manchester United and AS Roma ... International Champions Cup. The 2014 ICC is one of ... of the talent of it brings in. Teams like Real ... compete in the 2014 event spread across 10 American cities. ... game between Olympiacos and Milan and will conclude with the ...
(Date:7/13/2014)... An editorial published today in The Lancet ... into consideration the long term neurological problems that ... the most common form of sports-related traumatic brain ... concussions may include dementia, amyotrophic lateral sclerosis, and ... what is perhaps more concerning, is that even ...
(Date:7/13/2014)... 2014 Intraocular Lens (IOL) Market: Global ... - 2019 , Intraocular lens (IOL) is inserted in ... cataracts. The lenses are inserted inside the eye, after ... lens replaces the focusing power of natural lens. The ... to deliver the light focusing function which was originally ...
Breaking Medicine News(10 mins):Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 2Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 3Health News:Discover the Favorite Sublime Beauty® Citrus Scrub: Special "Two-Day Only" Sale 2Health News:Manchester United vs. AS Roma Tickets in Denver, CO at Sports Authority Field at Mile High: Ticket Down Slashes Ticket Prices on International Champions Cup in Denver 2Health News:Manchester United vs. AS Roma Tickets in Denver, CO at Sports Authority Field at Mile High: Ticket Down Slashes Ticket Prices on International Champions Cup in Denver 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4
... Parliament says that almost a thousand people end up in ... report, which was available in the parliament yesterday, showed that ... year." This was indeed a massive jump when compared with ... is growing at an alarming rate, so we need action ...
... health insurer has cut down payments for health care ... requested investigation //in to this matter. The insurers reduce ... independent physician are forced out of practice and have ... reply to this MedChi said in a letter to ...
... to place on record the exemplary work of art by students ... effort by Oman in the ‘Unite for children Unite against Aids’ ... ‘Unite for Children Unite Against Aids’ campaign encompasses four major goals ... the percentage of the young victims of HIV/Aids; to provide better ...
... hit by a rubella epidemic, with more than 6000 people ... worst affected//, said a Government health official. ,‘The ... 6,000,’ said Pham Ngoc Dinh, deputy director of the National ... largest outbreaks has been in Ho Chi Minh City's manufacturing ...
... Orthopedic surgeons at Rush University have developed ,the first ... has received clearance from the U.S. Food and Drug ... use next week. // ,Dr. Aaron G. Rosenberg and ... the 10 developer surgeons who sought to address shape-related ...
... in the promising field of nanotechnology, scientists have now ... tubes//. These findings have the potential to revolutionize cancer ... with anti-cancer drugs and injected into cancer patients, as ... tiniest tubes, scientists have made, are about 80 nanometres ...
Cached Medicine News:Health News:Shapelier Knee Replacements for Women 2Health News:Shapelier Knee Replacements for Women 3Health News:Shapelier Knee Replacements for Women 4Health News:Tiniest Nanoscale Test Tubes Corked; Holds Promise In Cancer Treatment 2
... system consists of four basic components: sample well ... clamping plate (see diagram). The sample well plate ... dots, or slots (see below). All three plates ... accessory plate in conjunction with a complete system. ...
... Bio-Dot SF (slot format) microfiltration units provide ... nucleic acid in solution onto nitrocellulose or ... accommodated by using interchangeable templates to form ... format Bio-Dot SF apparatus. Each is available ...
... SF (slot format) microfiltration units provide a ... acid in solution onto nitrocellulose or Zeta-Probe ... by using interchangeable templates to form the ... Bio-Dot SF apparatus. Each is available as ...
24-Well Slot Blot...
Medicine Products: